← Leaderboards
Andrea Pais
Novel Microdevices, Llc
$2,533,767
Attributed
$2,533,767
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2018–21$2M$1.5M$1M$500K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$2,533,767 · 3
By mechanism
R44$1,983,767 · 1
R43$300,000 · 1
N02$250,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Instrument”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Scott Dahm · Association Of Universities For Research In Astronomy, Inc.$48,619,671
- Laura Ferrarese · Association Of Universities For Research In Astronomy, Inc.$47,742,424
- John Hobbs · Suny At Stony Brook$42,194,917
- Christopher Bee · Suny At Stony Brook$41,239,084
- Robert D Blum · Association Of Universities For Research In Astronomy, Inc.$39,091,424
Research focus
InstrumentAssay DevelopmentWaiverNucleic AcidsBasePoint Of CareNucleic Acid Amplification TestsSwabEarly TreatmentAntibiotic ResistanceDiagnostic TestsChlamydia TrachomatisChronic Pelvic PainAutomationEctopic PregnancyDevicesBuffersDiagnosisClinical TrialsCostCellsDevice Or Instrument DevelopmentChlamydiaClinical Treatment
Grant awards (4)
Low Cost, Rapid Molecular Diagnostic for Chlamydia and Gonorrhea at the Point-of-Care$1,000,000
R44 · FY2021 · AI · contact PI
RADX-TECH- SUPPORT SERVICES NEEDED FOR WORK PACKAGE 1$250,000
N02 · FY2021 · HL · contact PI
Low Cost, Rapid Molecular Diagnostic for Chlamydia and Gonorrhea at the Point-of-Care$983,767
R44 · FY2020 · AI · contact PI
Low Cost, Rapid Molecular Diagnostic for Chlamydia and Gonorrhea at the Point-of-Care$300,000
R43 · FY2018 · AI · contact PI